Stada’s Rare Kidney Disease Drug Is EU First
Germany First In Line For The Orphan Disease Drug
Stada advances its Specialty ambitions by launching the EU’s first authorized treatment for the rare kidney disease immunoglobulin A nephropathy in the form of its modified-release budesonide capsules.
